title: Mifepristone in combination with methotrexate for the medical treatment of tubal pregnancy: a randomized, controlled trial.
abstract: In the search for a more potent alternative to a single i.m. injection of methotrexate for ectopic pregnancy, a randomized trial was organized. The efficacy of a combination of methotrexate and mifepristone was compared with methotrexate alone in the treatment of unruptured tubal pregnancies. The diagnosis of an unruptured tubal pregnancy was confirmed laparoscopically in 50 patients during a 2 year period. Women were randomized to receive a single i.m. injection of 50 mg/m2 methotrexate alone or a single dose of 600 mg oral mifepristone in combination with the same dose of methotrexate. Both treatment protocols were successful in achieving the resolution of unruptured ectopic pregnancy (18/25 in the methotrexate group and 22/25 in the combination group) following the initial intervention. A second injection was needed in four (16%) cases in the methotrexate group and in one (4%) case in the combination group. Overall, a complete resolution was achieved in 22/25 and 23/25 cases respectively. Unruptured ectopic pregnancy resolved faster in women given the combination of methotrexate and mifepristone compared to women given methotrexate only (P = 0.01). The effect of the methotrexate and mifepristone combination was more pronounced in women with higher human chorionic gonadotrophin concentrations.
authors.affiliation: Reproductive Medicine, Liverpool Women's Hospital, UK.
authors.forename: M R
authors.initials: MR
authors.lastname: Gazvani
authors.forename: D N
authors.initials: DN
authors.lastname: Baruah
authors.forename: Z
authors.initials: Z
authors.lastname: Alfirevic
authors.forename: S J
authors.initials: SJ
authors.lastname: Emery
mesh_terms: D000328:Adult; D006063:Chorionic Gonadotropin / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006727:Hormone Antagonists; D006801:Humans; D007813:Laparotomy; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D015735:Mifepristone / Q000008:administration & dosage / Q000627:therapeutic use*; D011247:Pregnancy; D011274:Pregnancy, Tubal / Q000188:drug therapy* / Q000601:surgery; D011372:Progestins / Q000037:antagonists & inhibitors*
chemical_list: D006063:Chorionic Gonadotropin; D006727:Hormone Antagonists; D011372:Progestins; D015735:Mifepristone; D008727:Methotrexate